Journal article
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
Nature and Science of Sleep, Vol.10, pp.377-383
2018
PMID: 30464665
Abstract
Purpose: Referrals to sleep psychology services, even for a perceived single problem such as insomnia, can present with complex, coexistent psychiatric symptoms and comorbid disorders. This study aimed to assess the feasibility of implementing the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure (CCSM) into a sleep psychology clinic to identify coexistent psychiatric symptomatology in insomnia referrals.
Patients and methods: Patients were 50 consecutive referrals to a private sleep psychology service within a sleep disorders center in Melbourne, Australia. Patients who attended sleep psychology services between June 2015 and January 2017 had their clinical records reviewed. Basic demographic information, comorbidities, and responses to the Insomnia Severity Index were gathered. The Diagnostic and Statistical Manual of Mental Disorders Ed. 5 Task Force and Work Groups created the CCSM in 2013 to deal with the issue of coexistent psychiatric symptomatology across mental health conditions, and this measure was included into the sleep psychology intake procedure and patient responses were reviewed.
Results: The CCSM was simple and quick to administer and score and revealed high levels of psychiatric symptomatology in sleep psychology referrals. Sleep problems were the most common domain of psychiatric symptomatology reported (86%). Anxiety (66%), depression (64%), anger (64%), and somatic symptoms (50%) were also very common. Suicidal ideation was acknowledged by 26% of patients. In addition, 82% of patients had at least one diagnosed comorbidity upon referral (eg, psychiatric, physical health, or other sleep disorder).
Conclusion: The findings support the CCSM as a feasible measure for identifying the high levels of coexistent psychiatric symptomatology in patients presenting for insomnia treatment at sleep psychology services.
Details
- Title
- The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
- Authors
- Hailey Meaklim - Melbourne Sleep Disorders CentreJohn Swieca - Melbourne Sleep Disorders CentreMoira F. Junge - Melbourne Sleep Disorders CentreIrena Laska - Melbourne Sleep Disorders CentreDanielle Kelly - St Vincent’s Private Hospital SydneyRosemarie Joyce - St Vincent’s Private Hospital SydneyDavid Cunnington (Corresponding Author) - Melbourne Sleep Disorders Centre
- Additional notes
- The data reported in this manuscript was presented as a poster at the 29th Annual Scientific Meeting of the Australasian Sleep Association and the Australasian Sleep Technologists Association, held on October 25–28, 2017, in Auckland, New Zealand. This manuscript was also accepted for a poster presentation at the 39th National Conference of the Australian Association for Cognitive and Behavioural Therapy, held on 25–27 October 2018 in Brisbane Australia.
- Publication details
- Nature and Science of Sleep, Vol.10, pp.377-383
- Publisher
- Dove Medical Press Ltd.
- Date published
- 2018
- DOI
- 10.2147/NSS.S173381
- ISSN
- 1179-1608
- PMID
- 30464665
- Copyright note
- © 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
- Organisation Unit
- Thompson Institute
- Language
- English
- Record Identifier
- 991239798802621
- Output Type
- Journal article
Metrics
1 Record Views